Research Articles | Page 6 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes Nov 2016 N Engl J Med myelodysplastic syndromes (MDS)
Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes Mar 2014 Expert Rev Anticancer Ther myelodysplastic syndromes (MDS)
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria Jan 2018 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms Mar 2014 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Jun 2020 Haematologica acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia Dec 2014 Hematology Am Soc Hematol Educ Program aplastic anemia
Timing of allogeneic stem cell transplantation for myelodysplastic syndromes and aplastic anemia Dec 2014 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated? Jul 2012 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Thrombosis in paroxysmal nocturnal hemoglobinuria. Apr 2013 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Thrombopoiesis-stimulating agents and myelodysplastic syndromes Feb 2015 Br J Haematol myelodysplastic syndromes (MDS)